Robert Scott Goodman, Chief Executive Officer at Beyond Air, Inc. (XAIR), bought 34,722 shares at $5.76 ($200K) on 2026-07-29, disclosed to the SEC on 2026-07-31.
CEO Robert Scott Goodman purchased $199,998.72 worth of shares at $5.76, a rare reversal that coincides with the stock trading 68.73% below its 52-week high. This insider buying during a steep 90-day decline of -46.71% may signal confidence in the company's upcoming FDA approval and growth trajectory.
The stock has crashed 40.54% over the last 30 days and is currently trading at $5.50, a 68.73% discount from its 52-week high of $17.59.
1) FDA approval decision for the next-gen device looms, with a Q1 2027 earnings call on 2026-08-14 discussing the decision. 2) The company reaffirmed ambitious 2027 growth targets and secured $30 million financing in a Q1 2027 earnings call on 2026-08-13. 3) The trade is flagged as the largest insider purchase ever, signaling a rare reversal.
The stock faces significant regulatory uncertainty, with recent news noting a 'reset' in analyst fair value estimates and a 'longer and more uncertain route to meaningful sales' for the LungFit PH system.
Clearly above the average filing.